Tech Company Financing Transactions

Vesigen Therapeutics Funding Round

Vesigen Therapeutics, based in Cambridge, scored $28.5 million from Leaps by Bayer, Morningside Group and Alexandria Venture Investments.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1 Kendall Sq. Building 200 001
Cambridge, MA 02139
USA

Phone

Undisclosed

Website

www.vesigentx.com

Email Address

[email protected]

Overview

Vesigen is developing groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. Our team is committed to leveraging ARMMs technology to enable new therapies and address currently unmet medical needs.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Robert Millman

        

Chief Financial Officer

David Neafus

        

Chief Operating Officer

Nicholas Buffinger

        

Vice President

Joseph Nabhan

        

Browse more venture capital transactions:

Prev: 7/24/2020: CyCognito venture capital transaction
Next: 7/24/2020: CalypsoAI venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary